Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies

[1]  B. Fischer.  Lessons Learned. , 2016, Schizophrenia bulletin.

[2]  F. Tiberg,et al.  Octreotide s.c. depot provides sustained octreotide bioavailability and similar IGF-1 suppression to octreotide LAR in healthy volunteers , 2015, British journal of clinical pharmacology.

[3]  George A. Calin,et al.  RNAi Therapies: Drugging the Undruggable , 2014, Science Translational Medicine.

[4]  Gang Zheng,et al.  Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. , 2014, ACS nano.

[5]  E. Takai,et al.  Arginine and lysine reduce the high viscosity of serum albumin solutions for pharmaceutical injection. , 2014, Journal of bioscience and bioengineering.

[6]  F. Tiberg,et al.  Octreotide fluid crystal provides sustained octreotide bioavailability and similar IGF1 suppression to that of octreotide LAR (Sandostatin LAR): randomized, open-label, Phase I, repeat-dose study in healthy volunteers , 2014 .

[7]  Norman J Wagner,et al.  Observation of small cluster formation in concentrated monoclonal antibody solutions and its implications to solution viscosity. , 2014, Biophysical journal.

[8]  David J Brayden,et al.  The role of citric acid in oral peptide and protein formulations: relationship between calcium chelation and proteolysis inhibition. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[9]  M. Álvarez,et al.  Estudio observacional de infusión subcutánea continua de insulina a lo largo de 7 años en el tratamiento de la diabetes mellitus tipo 1 , 2014 .

[10]  Tim R. Dargaville,et al.  Controlling microencapsulation and release of micronized proteins using poly(ethylene glycol) and electrospraying. , 2014, European journal of pharmaceutics and biopharmaceutics.

[11]  Panagiota Papargyri,et al.  An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus. , 2014, Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.

[12]  Jonathan M. Brunger,et al.  Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage , 2014, Proceedings of the National Academy of Sciences.

[13]  M. R. Sherman,et al.  Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins. , 2014, Molecular Immunology.

[14]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[15]  John Hardy,et al.  Antiamyloid therapy for Alzheimer's disease--are we on the right road? , 2014, The New England journal of medicine.

[16]  S. Mitragotri,et al.  Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Anirvan Ghosh,et al.  Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle , 2014, Neuron.

[18]  Chun-Xia Zhao,et al.  Nanoparticle vaccines. , 2014, Vaccine.

[19]  H. Gram,et al.  Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[20]  S. Mitragotri,et al.  Mucoadhesive intestinal devices for oral delivery of salmon calcitonin. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[21]  D. Holtzman,et al.  Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo , 2013, Neuron.

[22]  J. Lachowicz,et al.  Abstract P6-11-05: ANG4043, a brain-penetrant anti-HER2 mAb increases survival in mice bearing intracranial BT-474 breast tumor cells , 2013 .

[23]  J. Dumont,et al.  Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B. , 2013, The New England journal of medicine.

[24]  S. Mitragotri,et al.  A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Leslie R Evans,et al.  Albumin as a versatile platform for drug half-life extension. , 2013, Biochimica et biophysica acta.

[26]  R. Komotar,et al.  The role of Gliadel wafers in the treatment of high-grade gliomas , 2013, Expert review of anticancer therapy.

[27]  A. Chilkoti,et al.  A depot-forming glucagon-like peptide-1 fusion protein reduces blood glucose for five days with a single injection. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[28]  R. Langer,et al.  Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery , 2013, Science Translational Medicine.

[29]  David Goldstein,et al.  Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.

[30]  A. Mikos,et al.  Effect of temporally patterned TNF-α delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds , 2013, Journal of biomaterials science. Polymer edition.

[31]  S. Jon,et al.  Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[32]  D. Spector,et al.  Receptor-mediated delivery of engineered nucleases for genome modification , 2013, Nucleic acids research.

[33]  L. Vassilev,et al.  Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy , 2013, Proceedings of the National Academy of Sciences.

[34]  F. Sonntag,et al.  A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. , 2013, Lab on a chip.

[35]  R. Haag,et al.  Surfactant free preparation of biodegradable dendritic polyglycerol nanogels by inverse nanoprecipitation for encapsulation and release of pharmaceutical biomacromolecules. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[36]  K. Scearce-Levie,et al.  A Therapeutic Antibody Targeting Bace1 Inhibits Amyloid-beta Production in Vivo , 2013 .

[37]  T. Patapoff,et al.  Trehalose limits BSA aggregation in spray-dried formulations at high temperatures: implications in preparing polymer implants for long-term protein delivery. , 2013, Journal of pharmaceutical sciences.

[38]  G. Coukos,et al.  Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study , 2013, Cancer Immunology Research.

[39]  P. Wertz,et al.  Current Understanding of Skin Biology Pertinent to Skin Penetration: Skin Biochemistry , 2013, Skin Pharmacology and Physiology.

[40]  S. Mitragotri.  Engineering Approaches to Transdermal Drug Delivery: A Tribute to Contributions of Prof. Robert Langer , 2013, Skin Pharmacology and Physiology.

[41]  K. Scearce-Levie,et al.  Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier , 2013, Science Translational Medicine.

[42]  W. Pardridge,et al.  Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor , 2013, Biotechnology and bioengineering.

[43]  S. S. Matthews,et al.  Impact of site-specific PEGylation on the conformational stability and folding rate of the Pin WW domain depends strongly on PEG oligomer length. , 2013, Bioconjugate chemistry.

[44]  T. Bailey,et al.  A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults , 2013, The Journal of clinical endocrinology and metabolism.

[45]  E. Arbit,et al.  Glucose-Reducing Effect of the ORMD-0801 Oral Insulin Preparation in Patients with Uncontrolled Type 1 Diabetes: A Pilot Study , 2013, PloS one.

[46]  C. Harrison.  Deal watch: Chiasma and Roche partner in oral peptide drug delivery , 2013, Nature reviews. Drug discovery.

[47]  S. Schulte.  Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII. , 2013, Thrombosis research.

[48]  G. Pasut,et al.  Conjugation of hyaluronan to proteins. , 2013, Carbohydrate polymers.

[49]  A. Göpferich,et al.  Protein-polyanion interactions for the controlled release of monoclonal antibodies. , 2013, Biomacromolecules.

[50]  W. Banks,et al.  Conjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivo. , 2013, Molecular pharmaceutics.

[51]  Krishnendu Roy,et al.  Micro and Nanoparticle‐Based Delivery Systems for Vaccine Immunotherapy: An Immunological and Materials Perspective , 2013, Advanced healthcare materials.

[52]  Laurent Ducry,et al.  Antibody-Drug Conjugates , 2013, Methods in Molecular Biology.

[53]  Arianna Menciassi,et al.  Wearable and implantable pancreas substitutes , 2013, Journal of Artificial Organs.

[54]  Andrew Taberner,et al.  Needle-free jet injection using real-time controlled linear Lorentz-force actuators. , 2012, Medical engineering & physics.

[55]  H. Zisser,et al.  Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus. , 2012, Diabetes technology & therapeutics.

[56]  Richard A Flavell,et al.  Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy. , 2012, Nature materials.

[57]  M. Morfini,et al.  Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients. , 2012, Blood.

[58]  Elizabeth Nance,et al.  A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue , 2012, Science Translational Medicine.

[59]  Masakazu Hirose,et al.  Quality of Life and Technology: Impact on Children and Families With Diabetes , 2012, Current Diabetes Reports.

[60]  N. Binkley,et al.  A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[61]  Paolo De Coppi,et al.  Production and Implantation of Renal Extracellular Matrix Scaffolds From Porcine Kidneys as a Platform for Renal Bioengineering Investigations , 2012, Annals of surgery.

[62]  Francesco M Veronese,et al.  State of the art in PEGylation: the great versatility achieved after forty years of research. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[63]  C. Mirkin,et al.  Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation , 2012, Proceedings of the National Academy of Sciences.

[64]  Yun Yen,et al.  Preclinical study of the cyclodextrin-polymer conjugate of camptothecin CRLX101 for the treatment of gastric cancer. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[65]  J. Iqbal,et al.  In vivo evaluation of an oral drug delivery system for peptides based on S-protected thiolated chitosan. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[66]  Z. Su,et al.  A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. , 2012, Molecular pharmaceutics.

[67]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[68]  W. Stemmer,et al.  A Novel Long-Acting Human Growth Hormone Fusion Protein (VRS-317): Enhanced In Vivo Potency and Half-Life , 2012, Journal of pharmaceutical sciences.

[69]  Yanan Tan,et al.  Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[70]  Evripidis Gavathiotis,et al.  A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers. , 2012, The Journal of clinical investigation.

[71]  M. Rathbone,et al.  Recent developments in buccal and sublingual delivery systems , 2012, Expert opinion on drug delivery.

[72]  Mark E. Davis,et al.  Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[73]  P. Uzor,et al.  Transdermal Drug Delivery , 2012 .

[74]  Robert Langer,et al.  Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile , 2012, Science Translational Medicine.

[75]  R. Reid,et al.  Predictable and tunable half-life extension of therapeutic agents by controlled chemical release from macromolecular conjugates , 2012, Proceedings of the National Academy of Sciences.

[76]  H. Shepard,et al.  Effective targeting of the tumor microenvironment for cancer therapy. , 2012, Anticancer research.

[77]  R. Kontermann,et al.  Therapeutic Proteins: Strategies to Modulate Their Plasma Half-Lives , 2012 .

[78]  Theodore W Randolph,et al.  Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. , 2012, Journal of pharmaceutical sciences.

[79]  Seeram Ramakrishna,et al.  Advances in polymeric systems for tissue engineering and biomedical applications. , 2012, Macromolecular bioscience.

[80]  Robert Langer,et al.  First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip , 2012, Science Translational Medicine.

[81]  Y. Kwak,et al.  The effect of SonoPrep® on EMLA® cream application for pain relief prior to intravenous cannulation , 2012, European Journal of Pediatrics.

[82]  M. R. Sherman,et al.  Role of the Methoxy Group in Immune Responses to mPEG-Protein Conjugates , 2012, Bioconjugate chemistry.

[83]  T. Hey,et al.  Half‐Life Extension through HESylation® , 2012 .

[84]  A. Fischman,et al.  CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder , 2012, PloS one.

[85]  Ulrik B. Nielsen,et al.  Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3 , 2012, Molecular Cancer Therapeutics.

[86]  J. Andersen,et al.  Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor , 2012, Nature Communications.

[87]  W. V. Osdol,et al.  In Situ Forming Systems (Depots) , 2012 .

[88]  Yoshio Kato,et al.  targeted gene knockout by direct delivery of zinc-finger nuclease proteins , 2012 .

[89]  D. Burgess,et al.  Long Acting Injections and Implants , 2012, Advances in Delivery Science and Technology.

[90]  P Schaepelynck,et al.  Advances in pump technology: insulin patch pumps, combined pumps and glucose sensors, and implanted pumps. , 2011, Diabetes & metabolism.

[91]  M. Trautmann,et al.  Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes. , 2011, Diabetes technology & therapeutics.

[92]  S. Mitragotri,et al.  Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer , 2011, Proceedings of the National Academy of Sciences.

[93]  P. Davies,et al.  Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models , 2011, The Journal of Biological Chemistry.

[94]  Cindi M Morshead,et al.  Controlled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell proliferation in stroke-injured brain. , 2011, Biomaterials.

[95]  Tina N. Davis,et al.  A class of human proteins that deliver functional proteins into mammalian cells in vitro and in vivo. , 2011, Chemistry & biology.

[96]  R. Murthy,et al.  Opsonization, Biodistribution, Cellular Uptake and Apoptosis Study of PEGylated PBCA Nanoparticle as Potential Drug Delivery Carrier , 2011, Pharmaceutical Research.

[97]  C. Tack,et al.  Improved Pharmacokinetic and Pharmacodynamic Profile of Rapid-Acting Insulin Using Needle-Free Jet Injection Technology , 2011, Diabetes Care.

[98]  W. Luk,et al.  Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target , 2011, Science Translational Medicine.

[99]  K. Scearce-Levie,et al.  A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo , 2011, Science Translational Medicine.

[100]  E. Masliah,et al.  Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease , 2011, PloS one.

[101]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[102]  Jason A. Burdick,et al.  Hyaluronic Acid Hydrogels for Biomedical Applications , 2011, Advanced materials.

[103]  A. Klibanov,et al.  Hydrophobic salts markedly diminish viscosity of concentrated protein solutions , 2011, Biotechnology and bioengineering.

[104]  A. Hoffman,et al.  Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier. , 2011, Reactive & functional polymers.

[105]  M. Prausnitz,et al.  Microneedle Vaccination with Stabilized Recombinant Influenza Virus Hemagglutinin Induces Improved Protective Immunity , 2011, Clinical and Vaccine Immunology.

[106]  C. Duvall,et al.  Intracellular delivery of a protein antigen with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic vaccine efficacy. , 2010, Bioconjugate chemistry.

[107]  Sandeep Yadav,et al.  Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies. , 2010, Journal of pharmaceutical sciences.

[108]  R. Luxenhofer,et al.  Protein modification with amphiphilic block copoly(2-oxazoline)s as a new platform for enhanced cellular delivery. , 2010, Molecular pharmaceutics.

[109]  C. Davis,et al.  Microneedle Delivery of H5N1 Influenza Virus-Like Particles to the Skin Induces Long-Lasting B- and T-Cell Responses in Mice , 2010, Clinical and Vaccine Immunology.

[110]  V. Koul,et al.  Investigation on the synergistic effect of a combination of chemical enhancers and modulated iontophoresis for transdermal delivery of insulin , 2010, Drug development and industrial pharmacy.

[111]  David R. Liu,et al.  Potent Delivery of Functional Proteins into Mammalian Cells in Vitro and in Vivo Using a Supercharged Protein , 2010, ACS chemical biology.

[112]  S. Mitragotri,et al.  Ultrasound-Enhanced Drug Transport and Distribution in the Brain , 2010, AAPS PharmSciTech.

[113]  Soong Ho Um,et al.  Therapeutic cell engineering using surface-conjugated synthetic nanoparticles , 2010, Nature Medicine.

[114]  Erkki Ruoslahti,et al.  Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.

[115]  Charles Tator,et al.  Poly(ethylene glycol) modification enhances penetration of fibroblast growth factor 2 to injured spinal cord tissue from an intrathecal delivery system. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[116]  D. Benoit,et al.  Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer. , 2010, Molecular pharmaceutics.

[117]  W. Banks,et al.  Transport across the Blood-Brain Barrier of Pluronic Leptin , 2010, Journal of Pharmacology and Experimental Therapeutics.

[118]  JaneR . Taylor,et al.  The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats , 2010, Brain Research.

[119]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[120]  M. Karsdal,et al.  The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. , 2010, Osteoarthritis and cartilage.

[121]  P. Raskin,et al.  Review of clinical trials: update on oral insulin spray formulation , 2010 .

[122]  J. Desjarlais,et al.  Enhanced antibody half-life improves in vivo activity , 2010, Nature Biotechnology.

[123]  Tetsu Kobayashi,et al.  Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR , 2010, The Journal of Immunology.

[124]  Matthew H. M. Lim,et al.  Perfused multiwell plate for 3D liver tissue engineering. , 2010, Lab on a chip.

[125]  Raymond E. Moellering,et al.  Direct inhibition of the NOTCH transcription factor complex , 2010, Nature.

[126]  Martin Körber,et al.  Improved Lysozyme Stability and Release Properties of Poly(lactide-co-glycolide) Implants Prepared by Hot-Melt Extrusion , 2010, Pharmaceutical Research.

[127]  David J Brayden,et al.  Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic. , 2009, Advanced drug delivery reviews.

[128]  Willem P C Stemmer,et al.  A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner , 2009, Nature Biotechnology.

[129]  J. Rosenstock,et al.  Safety and efficacy of inhaled human insulin (exubera) during discontinuation and readministration of therapy in adults with type 2 diabetes: a 3-year randomized controlled trial. , 2009, Diabetes technology & therapeutics.

[130]  A. Daugherty,et al.  Proteins and Peptides : Pharmacokinetic, Pharmacodynamic, and Metabolic Outcomes , 2009 .

[131]  Seiichi Funamoto,et al.  In vivo evaluation of a novel scaffold for artificial corneas prepared by using ultrahigh hydrostatic pressure to decellularize porcine corneas , 2009, Molecular vision.

[132]  M. S. Muthu,et al.  PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[133]  Samir Mitragotri,et al.  Transcutaneous immunization using common chemicals. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[134]  J. Marvin,et al.  Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates , 2009, The Journal of Immunology.

[135]  M. Bush,et al.  Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long‐acting glucagon‐like peptide‐1 mimetic, in healthy subjects , 2009, Diabetes, obesity & metabolism.

[136]  Howard C. Zisser,et al.  Clinical Update on Optimal Prandial Insulin Dosing Using a Refined Run-to-Run Control Algorithm , 2009, Journal of diabetes science and technology.

[137]  Michael S. Goldberg,et al.  Development of lipidoid-siRNA formulations for systemic delivery to the liver. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[138]  K. Chester,et al.  Site-specific polysialylation of an antitumor single-chain Fv fragment. , 2009, Bioconjugate chemistry.

[139]  E. Miele,et al.  Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer , 2009, International journal of nanomedicine.

[140]  Samir Mitragotri,et al.  Dynamic control of needle-free jet injection. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[141]  N. Smith,et al.  Dose comparison of ultrasonic transdermal insulin delivery to subcutaneous insulin injection , 2008, International journal of nanomedicine.

[142]  B. Kerwin.  Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. , 2008, Journal of pharmaceutical sciences.

[143]  S. Mitragotri,et al.  Discovery of synergistic permeation enhancers for oral drug delivery. , 2008, Journal of Controlled Release.

[144]  Nicholas A Peppas,et al.  Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery. , 2008, Biomacromolecules.

[145]  G. Hardee,et al.  Oral delivery of antisense oligonucleotides in man. , 2008, Journal of pharmaceutical sciences.

[146]  M. Castelli,et al.  Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects , 2007, Journal of clinical pharmacology.

[147]  David J Mooney,et al.  Spatiotemporal control over growth factor signaling for therapeutic neovascularization. , 2007, Advanced drug delivery reviews.

[148]  H Lennernäs,et al.  Intestinal permeability and its relevance for absorption and elimination , 2007, Xenobiotica; the fate of foreign compounds in biological systems.

[149]  K. Lundstrom,et al.  Review on Medusa®:a polymer-based sustained release technology for protein and peptide drugs , 2007, Expert opinion on drug delivery.

[150]  Samir Mitragotri,et al.  Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets , 2007, Proceedings of the National Academy of Sciences.

[151]  D J Mooney,et al.  Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis , 2007, Journal of thrombosis and haemostasis : JTH.

[152]  S. Korsmeyer,et al.  A stapled BID BH3 helix directly binds and activates BAX. , 2006, Molecular cell.

[153]  N. Peppas,et al.  Is the oral route possible for peptide and protein drug delivery? , 2006, Drug discovery today.

[154]  S. Mitragotri,et al.  Needle-free liquid jet injections: mechanisms and applications , 2006, Expert review of medical devices.

[155]  Randall J Mrsny,et al.  Formulation and delivery issues for monoclonal antibody therapeutics. , 2006, Advanced drug delivery reviews.

[156]  D. Jacqmin,et al.  Pharmacokinetics (PK) and immunologic responses in a phase I/II study of a sustained release formulation of IL-2 in renal cell carcinoma (RCC) patients. , 2006, Journal of Clinical Oncology.

[157]  A. G. Ding,et al.  Prediction of microclimate pH in poly(lactic-co-glycolic acid) films. , 2006, Journal of the American Chemical Society.

[158]  Wenjuan Yang,et al.  Transdermal protein delivery by a coadministered peptide identified via phage display , 2006, Nature Biotechnology.

[159]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[160]  B. Silverman,et al.  Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone. , 2006, Alcoholism, clinical and experimental research.

[161]  Nicholas A Peppas,et al.  Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[162]  G. Verdine.  Drugging the "undruggable". , 2006, Harvey lectures.

[163]  K. Srivenugopal,et al.  RETRACTED: Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels , 2005, Journal of drug targeting.

[164]  Y. Kalia,et al.  Effect of Charge and Molecular Weight on Transdermal Peptide Delivery by Iontophoresis , 2005, Pharmaceutical Research.

[165]  Steven J Shire,et al.  Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. , 2005, Journal of pharmaceutical sciences.

[166]  D. Mooney,et al.  Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) , 2005, Gene Therapy.

[167]  F. Ahsan,et al.  Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin , 2005, Journal of drug targeting.

[168]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[169]  Mark E. Davis,et al.  Cyclodextrin-based pharmaceutics: past, present and future , 2004, Nature Reviews Drug Discovery.

[170]  Samir Mitragotri,et al.  Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[171]  A. Margolin,et al.  Injectable controlled release formulations incorporating protein crystals. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[172]  Jennifer L Davis,et al.  Novel approaches to ocular drug delivery. , 2004, Current opinion in molecular therapeutics.

[173]  M. Kermode.  Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. , 2004, Health promotion international.

[174]  L. Klumb,et al.  Poly(Lactide-Co-Glycolide) Microsphere Formulations of Darbepoetin Alfa: Spray Drying Is an Alternative to Encapsulation by Spray-Freeze Drying , 2004, Pharmaceutical Research.

[175]  K. J. Brodbeck,et al.  Sustained Release of Human Growth Hormone from PLGA Solution Depots , 1999, Pharmaceutical Research.

[176]  Robert Langer,et al.  Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres , 1991, Pharmaceutical Research.

[177]  A. Griesmacher,et al.  Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty , 2004, Journal of Bone and Mineral Metabolism.

[178]  Robert Langer,et al.  Multi-pulse drug delivery from a resorbable polymeric microchip device , 2003, Nature materials.

[179]  Jagdish Singh,et al.  Electronically facilitated transdermal delivery of human parathyroid hormone (1-34). , 2003, International journal of pharmaceutics.

[180]  J. Egrie,et al.  Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. , 2003, Experimental hematology.

[181]  A. Minton,et al.  Effect of dextran on protein stability and conformation attributed to macromolecular crowding. , 2003, Journal of molecular biology.

[182]  L. Illum.  Nasal drug delivery--possibilities, problems and solutions. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[183]  G. Hardee,et al.  Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[184]  J. Cleland,et al.  Sustained delivery of human growth hormone from a novel gel system: SABER. , 2002, Biomaterials.

[185]  Robert Langer,et al.  Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[186]  S. Yalkowsky,et al.  Review on the systemic delivery of insulin via the ocular route. , 2002, International journal of pharmaceutics.

[187]  N. Shibata,et al.  Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein. , 2002, Biomaterials.

[188]  E. Mini,et al.  Clinical Pharmacokinetics of Depot Leuprorelin , 2002, Clinical pharmacokinetics.

[189]  F. Newman,et al.  Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. , 2001, Vaccine.

[190]  J. Mestecky,et al.  Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[191]  J. Rothbard,et al.  Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation , 2000, Nature Medicine.

[192]  R. Motter,et al.  Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.

[193]  H. Ravivarapu,et al.  Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate. , 2000, Journal of pharmaceutical sciences.

[194]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[195]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[196]  T. Park,et al.  Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. , 1999, Biotechnology and bioengineering.

[197]  B. Chang,et al.  Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. , 1999, Archives of biochemistry and biophysics.

[198]  Scott D. Putney,et al.  Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.

[199]  N Lotan,et al.  Large porous particles for pulmonary drug delivery. , 1997, Science.

[200]  R. Ranganathan,et al.  Structural and Functional Analysis of the Mitotic Rotamase Pin1 Suggests Substrate Recognition Is Phosphorylation Dependent , 1997, Cell.

[201]  R. Gupta,et al.  Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[202]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[203]  R. Langer,et al.  Controlled release of polypeptides from polyanhydrides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[204]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[205]  K. Whaley,et al.  Macromolecules released from polymers: diffusion into unstirred fluids. , 1990, Biomaterials.

[206]  E. Thompson,et al.  Laboratory Investigation of Cerebrospinal Fluid Proteins , 1990, Annals of clinical biochemistry.

[207]  T. Y. Tsang.  Mechanisms and Applications , 1989 .

[208]  R. Langer,et al.  Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.